HCA Healthcare (HCA) Releases Financial and Operating Results for Q2 2025

HCA Healthcare, Inc. (NYSE:HCA) is one of the Best Stocks to Buy According to Abrams Bison Investments. On July 25, the company released its financial and operating results for Q2 2025, which demonstrated healthy revenue growth, improved margins, and better outcomes for its patients. HCA Healthcare, Inc. (NYSE:HCA) saw revenues of $18.605 billion in Q2 2025 as compared to $17.492 billion in Q2 2024. For FY 2025, the company expects adjusted EBITDA of between $14.70 billion – $15.30 billion, an increase from the prior guidance of $14.30 billion – $15.10 billion.

HCA Healthcare (HCA) Releases Financial and Operating Results for Q2 2025

A team of healthcare professionals in lab coats and masks meeting at a hospital ward.

On July 28, Morgan Stanley analyst Craig Hettenbach reduced the price objective on the company’s stock to $400 from $410, while keeping an “Equal Weight” rating. As per the firm analyst, amidst a noisy backdrop for hospital stocks, HCA Healthcare, Inc. (NYSE:HCA)’s diversified business, robust track record, and aggressive cash returns to shareholders remain favourable indicators. That being said, some more clarity on the Health Insurance Exchange marketplace into 2026 might be required for multiple expansion, believes Hettenbach.

Alluvium Asset Management, an asset management company, released its Q1 2025 investor letter. Here is what the fund said:

HCA Healthcare, Inc. (NYSE:HCA), the hospital and ambulatory site owner/operator, (up 15.4%) released its full year results. Management provided 2025 guidance of revenue up 5.2% and EPS up 13.4% – a little above our estimate of its maintainable earnings. We suspect the concerns over possible regulatory changes (which we wrote about here) have been put on the back burner whilst the market digests the tariff implications. We ended the quarter with a 7.9% position, which, given its current price and our view of its value, we are reasonably comfortable with.”

While we acknowledge the potential of HCA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than HCA and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now

Disclosure: None. This article is originally published at Insider Monkey.